Teodora Radonic

DR.

20132020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2019

A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape Project

Kerr, K. M., Thunnissen, E., Dafni, U., Finn, S. P., Bubendorf, L., Soltermann, A., Verbeken, E., Biernat, W., Warth, A., Marchetti, A., Speel, E-J. M., Pokharel, S., Quinn, A. M., Monkhorst, K., Navarro, A., Madsen, L. B., Radonic, T., Wilson, J., de Luca, G., Gray, S. G. & 17 others, Cheney, R., Savic, S., Martorell, M., Muley, T., Baas, P., Meldgaard, P., Blackhall, F., Dingemans, A-M., Dziadziuszko, R., Vansteenkiste, J., Weder, W., Polydoropoulou, V., Geiger, T., Kammler, R., Peters, S., Stahel, R. & Lungscape Consortium, 1 May 2019, In : Lung Cancer. 131, p. 95-103

Research output: Contribution to journalArticleAcademicpeer-review

Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer

van Veggel, B., Madeira R Santos, J. F. V., Hashemi, S. M. S., Paats, M. S., Monkhorst, K., Heideman, D. A. M., Groves, M., Radonic, T., Smit, E. F., Schuuring, E., van der Wekken, A. J. & de Langen, A. J., 20 Dec 2019, In : Lung Cancer. 141, p. 9-13 5 p.

Research output: Contribution to journalArticleAcademicpeer-review

2018

Crizotinib treatment for patients with EGFR mutation positive NSCLC that acquire cMET amplification after EGFR TKI therapy results in short-lived and heterogeneous responses

van Veggel, B., de Langen, A. J., Hashemi, S., Monkhorst, K., Rosenberg, E. H., Heideman, D. A. M., Radonic, T. & Smit, E. F., 2018, In : Lung Cancer. 124, p. 130-134 5 p.

Research output: Contribution to journalArticleAcademicpeer-review

Osimertinib treatment for patients with EGFR exon 20 insertion positive non-small cell lung cancer

van Veggel, B., van der Wekken, A., Hashemi, S., Cornelissen, R., Monkhorst, K., Heideman, D., Radonic, T., Smit, E. F., Schuuring, E. & De Langen, J., 1 Oct 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii524-viii525

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

P2.13-42 Osimertinib Treatment for Patients with EGFR exon 20 Insertion Positive Non-Small-Cell Lung Cancer

Van Veggel, B., Van Der Wekken, A., Hashemi, S., Cornelissen, R., Monkhorst, K., Heideman, D., Radonic, T., Schuuring, E., Smit, E. & De Langen, J., 22 Oct 2018, In : Journal of Thoracic Oncology. 13, 10, p. S815

Research output: Contribution to journalArticleAcademic

2015

Beneficial Outcome of Losartan Therapy Depends on Type of FBN1 Mutation in Marfan Syndrome

Franken, R., den Hartog, A. W., Radonic, T., Micha, D., Maugeri, A., van Dijk, F. S., Meijers-Heijboer, H. E., Timmermans, J., Scholte, A. J., van den Berg, M. P., Groenink, M., Mulder, B. J. M., Zwinderman, A. H., de Waard, V. & Pals, G., 2015, In : Circulation-cardiovascular genetics. 8, 2, p. 383-388

Research output: Contribution to journalArticleAcademicpeer-review

The revised role of TGF-beta in aortic aneurysms in Marfan syndrome

Franken, R., Radonic, T., den Hartog, A. W., Groenink, M., Pals, G., van Eijk, M., Lutter, R., Mulder, B. J. M., Zwinderman, A. H. & de Waard, V., 2015, In : Netherlands Heart Journal. 23, 2, p. 116-121

Research output: Contribution to journalArticleAcademicpeer-review

2014

No Beneficial Effect of General and Specific Anti-Inflammatory Therapies on Aortic Dilatation in Marfan Mice

Franken, R., Hibender, S., den Hartog, A. W., Radonic, T., de Vries, C. J. M., Zwinderman, A. H., Groenink, M., Mulder, B. J. M. & de Waard, V., 2014, In : PLoS ONE. 9, 9, e107221.

Research output: Contribution to journalArticleAcademicpeer-review

2013

Aortic Disease in Patients with Marfan Syndrome: Aortic Volume Assessment for Surveillance

den Hartog, A. W., Franken, R., de Witte, P., Radonic, T., Marquering, H. A., van der Steen, W. E., Timmermans, J., Scholte, A. J., van den Berg, M. P., Zwinderman, A. H., Mulder, B. J. M. & Groenink, M., 2013, In : Radiology. 269, 2, p. 369-376

Research output: Contribution to journalArticleAcademicpeer-review

Circulating transforming growth factor-beta as a prognostic biomarker in Marfan syndrome

Franken, R., den Hartog, A. W., de Waard, V., Engele, L., Radonic, T., Lutter, R., Timmermans, J., Scholte, A. J., van den Berg, M. P., Zwinderman, A. H., Groenink, M. & Mulder, B. J. M., 2013, In : International Journal of Cardiology. 168, 3, p. 2441-2446

Research output: Contribution to journalArticleAcademicpeer-review

Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial

Groenink, M., den Hartog, A. W., Franken, R., Radonic, T., de Waard, V., Timmermans, J., Scholte, A. J., van den Berg, M. P., Spijkerboer, A. M., Marquering, H. A., Zwinderman, A. H. & Mulder, B. J. M., 2013, In : European Heart Journal. 34, 45, p. 3491-3500

Research output: Contribution to journalArticleAcademicpeer-review